View in EDS HTML Full Text PDF Full Text

Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors.

Saved in:
Bibliographic Details
Title: Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors.
Authors: Stradella, Agostina1 (AUTHOR), Johnson, Melissa2 (AUTHOR), Goel, Sanjay3 (AUTHOR), Park, Haeseong4,5 (AUTHOR), Lakhani, Nehal6 (AUTHOR), Arkenau, Hendrik‐Tobias7 (AUTHOR), Galsky, Matthew D.8 (AUTHOR), Calvo, Emiliano9 (AUTHOR), Baz, Vicente10 (AUTHOR), Moreno, Victor11 (AUTHOR), Saavedra, Omar12 (AUTHOR), Luen, Stephen J.13,14 (AUTHOR), Mu, Song15 (AUTHOR), Wan, Qiting16 (AUTHOR), Chang, Victoria17 (AUTHOR), Zhang, Wa16 (AUTHOR), Barve, Minal18 (AUTHOR) mbarve@marycrowley.org
Source: Cancer Medicine. Jul2024, Vol. 13 Issue 13, p1-19. 19p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20457634
DOI:10.1002/cam4.7385